NeuBase Therapeutics Inc (NBSE)
Market Closed
10 May, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
0. 38
-0.01
-1.5625%
$
1.42M Market Cap
- P/E Ratio
- Div Yield
89,703 Volume
0 Eps
$ 0.38
Previous Close 
Want to track NBSE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NeuBase Therapeutics Inc (NBSE) Statistics
Valuation metrics
Market Cap 1.42M
Enterprise value -15.74M
Trailing P/E (ttm) -0.02
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) 0.03
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.48
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 0.36
52-Week high 4.44
Beta -
50-Day moving average -
200-Day moving average -
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 15 Jun 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.05%
Return on equity -0.89%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -21.08
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 14.25
Total debt (mrq) -
Total Debt/Equity (mrq) 0.26
Current ratio (mrq) 5.92%
Book value per share (mrq) 14.28
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
